In 2023, the mortality rate for genitourinary system diseases among females in Japan stood at a projected base before the forecast period. In 2024, the mortality is forecasted at 24.79 thousand, rising progressively to 26.88 thousand by 2028. The projected year-on-year growth rates between these years reveal a consistent increase, averaging around 2% annually. The compounded annual growth rate (CAGR) over this five-year span is approximately 2.0%, indicating a steady upward trend in mortality rates.
Future trends to watch for include advancements in medical technology and treatment which could potentially decelerate this increase. Additionally, addressing underlying risk factors and promoting early detection might influence this forecast positively.
